SPOTLIGHT: Investors expected to boost GSK, AZ


Credit Suisse lifted its share-price targets for GlaxoSmithKline, AstraZeneca, and Shire, saying it expects the pharma sector to be something of a port in a storm for investors worried about the economy. Report